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Summary 
In rat neostriatal neurons, D1 dopamine receptors 
regulate the activity of cyclic AMP-dependent protein 
kinase (PKA) and protein phosphatase 1 (PP1). The 
influence of these signaling elements on high voltage- 
activated (HVA) calcium currents was studied using 
whole-cell voltage-clamp techniques. The application 
of D1 agonists or cyclic AMP analogs reversibly re- 
duced N- and P-type Ca 2+ currents. Inhibition of PKA 
antagonized this modulation, as did inhibition of PP1, 
suggesting that the D~ effect was mediated by a PKA 
enhancement of PP1 activity directed toward Ca 2+ 
channels. In a subset of neurons, D~ receptor-medi- 
ated activation of PKA enhanced L-type currents. The 
differential regulation of HVA currents by the D1 path- 
way helps to explain the diversity of effects this path- 
way has on synaptic integration and plasticity in me- 
dium spiny neurons. 
Introduction 
The cellular signaling pathways utilized by dopamine in 
the neostriatum are of broad clinical interest. Disorders 
in dopaminergic signaling are thought to underlie not only 
Parkinson's disease but also a variety of other psychomo- 
tor syndromes, including schizophrenia (Kopin, 1993; 
Nemeroff and Bissette, 1988). In recent years, rapid prog- 
ress has been made in characterizing the receptors me- 
diating the cellular response to dopamine (Sibley and 
Monsma, 1992). Cloning studies have revealed five recep- 
tor subtypes that are homologous to other G protein-cou- 
pled receptors. Each of these receptors is expressed to 
a varying degree by neostriatal neurons, with D~a and D2 
receptors being the most abundant. In contrast to the de- 
tailed characterization of the receptors themselves, rela- 
tively little is known about how these receptors couple to 
intracellular signaling pathways and ion channels. 
The best-characterized of the cloned receptors from this 
standpoint is the Dla receptor. This receptor positively cou- 
ples to adenylyl cyclase through a Gs- or Go,f-class protein 
(Sibley and Monsma, 1992; Herve et al., 1993). These 
G proteins activate adenylyl cyclase, elevating cytosolic 
cyclic AMP (cAMP), which in turn induces the dissociation 
of the regulatory subunit from cAMP-dependent protein 
kinase (PKA; Gilman, 1987). By phosphorylating targeted 
proteins, PKA is capable of altering a variety of cellular 
functions (Walaas and Greengard, 1991). Among the pro- 
teins containing phosphorylation sites for PKA are the 
pore-forming subunits (or1 subunit) of N- and L-type Ca 2+ 
channels (Hell et al., 1993b, 1994). Phosphorylation of 
these sites enhances whole-cell Ca 2+ currents carried by 
these channels (Trautwein and Hescheler, 1990; Gross 
et al., 1990; Hartzell et al., 1991). Dephosphorylation of 
these sites is regulated by protein phosphatases 1 (PP1) 
and 2A (PP2A; Hescheler et al., 1987; Shenolikar and 
Nairn, 1991; Lai et al., 1993). These phosphatases are 
controlled by binding or targeting proteins (Hubbard and 
Cohen, 1993) and by cytosolic inhibitor phosphoproteins 
like dopamine and cAMP-regulated phosphoprotein 
(DARPP-32; Hemmings et al., 1990). All of these signaling 
elements--from receptor to channel--are expressed by 
medium-sized neostriatal neurons (Hemmings et al., 
1990; Anderson and Reiner, 1990; Hoehn et al., 1993; 
Bargas et al., 1994; Ouimet, da Cruz e Silva, and 
Greengard, unpublished data), but it is unclear how their 
interactions are orchestrated in controlling cellular physi- 
ology. 
Several observations indirectly suggest that the D1 path- 
way is involved in a variety of cellular processes, including 
synaptic integration and plasticity. In striatal slices, for 
example, the application of D1 agonists decreases the size 
of evoked excitatory postsynaptic potentials (EPSPs; Ca- 
labresi et al., 1987; Cepeda et al., 1993). In other neurons, 
dendritic high voltage-activated (HVA) Ca 2÷ currents are 
crucial to the conveyance of elect rotonically remote synap- 
tic events to the soma (Kim and Connors, 1993; Reuveni 
et al., 1993), suggesting that modulation of these currents 
is one mechanism by which D1 receptors attenuate synap- 
tic inputs. Sustained changes in synaptic strength also 
depend upon Ca 2+ entry. One example is long-term synap- 
tic depression (LTD). In the hippocampus, LTD is depen- 
dent upon postsynaptic Ca 2+ entry and activation of PP1 
(Mulkey et al., 1994). In the neostriatum, LTD induction 
requires activation of D~ receptors, suggesting that these 
receptors regulate one or both signals (Calabresi et al., 
1992). Lastly, in addition to influencing Ca2+-dependent 
release of y-aminobutydc acid (FIoran et al., 1990), D~ ago- 
nists enhance the expression of the immediate arly gene 
c-fos in some medium spiny neurons (Robertson et al., 
1990, 1992). This effect may be due in part to relief of the 
Ca2+-dependent transcriptional block of this gene (Collart 
et al., 1991 ; G inty et al., 1993; Murphy et al., 1991 ; Bading 
et al., 1993). While suggestive when taken together, none 
of these studies provides definitive vidence that D~ recep- 
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Figure 1. Medium-Sized Striatal Neurons Were lsolated from the Dor- 
sal, Precommissural Neostriatum 
(A) Schematic diagram of a frontal section of a rat brain showing the 
region (hatched) of the striatum taken for dissociation. 
(B) Photomicrographs of medium and large, acutely dissociated rat 
neostriatal neurons. Recordings were taken only from medium-sized 
neurons; the large neuron is identified by an asterisk. The inset is a 
histogram of whole-cell capacitances in a random sa ple of neostriatal 
neurons. Note that the distribution is bimodal. Recordings reported 
here were restricted to medium-sized neurons with whole-cell capaci- 
tances between 3 and 9 pF (shaded area). 
tors exert their effects, in whole or part, through the PKA 
cascade by modulating HVA Ca 8+ channels. In this report, 
we provide direct evidence that this is the case. Acting 
through the well-described stimulation of adenylyl cyclase 
and PKA, D~-class receptors reduce N- and P-type Ca 9+ 
currents. This modulation appears not to be mediated by 
PKA directly but by a transient PKA enhancement of PP1 
activity directed toward Ca 9+ channels. In contrast, L-type 
currents are directly augmented by PKA in a subset of 
neurons. Together, these results provide a cellular frame- 
work within which the effects of dopamine on short-term 
excitability, synaptic plasticity, and gene expression can 
be understood. 
Results 
Because of the histochemical differences between neo- 
striatal regions (Gerfen, 1992), tissue was taken exclu- 
sively from the dorsal half of the precommissural neostria- 
tum (Figure 1A). Neurons dissociated from this region 
typically had either medium or large somal diameters (Fig- 
ure 1B); these differences were reflected in the bimodal 
distribution of whole-cell capacitance (Figure 1B, inset). 
Only medium-sized neurons with a whole-cell capacitance 
between 3 and 9 pF were used in this study. Previous 
work using retrograde labeling or single-cell expression 
profiling (Surmeier et al., 1992) has shown that this group 
was composed largely of medium spiny neurons (which 
make up about 95% of all neurons in the neostriatum). 
D~ Agonists Reduce HVA Ca 9+ Currents through a 
G Protein-Dependent Pathway 
The application of dopamine or D~-class agonists (SKF 
38393, 6-chloro-APB, and 6-chloro-PB) reversibly reduced 
whole-cell Ca 2+ currents in the majority of neurons (67%; 
n = 87). At subsaturating agonist concentrations, the mod- 
ulation was relatively slow in onset, usually taking 10-  
20 s to stabilize. Washing off the agonist led to a slow, 
exponential return to control current levels in most cells 
(Figures 2A and 2B). The median reduction in peak current 
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Figure 2. D~ Agonists Reversibly Decrease 
N- and P-type HVA Ca 2÷ Currents in Acutely 
Isolated, Adult Rat Neostriatal Neurons 
(A) Plot of peak current as a function of time 
after seal rupture. The D~ agonist 6-chloro-APB 
(500 nM) reversibly reduced current ampli- 
tudes. 
(B) Current traces taken from the records used 
to construct (A). The point in the time course 
from which the records were taken is denoted 
by an asterisk in (A). The inset is a box plot 
summary of the percentage reduction in peak 
current produced by D1 agonists in a sample 
of 20 neurons. 
(C) The modulation by the D~ agonist SKF 
38393 was blocked by SCH 23390 (1 #M). 
Shown are currents evoked by a step depolar- 
ization in control solutions, after coapplication 
of SCH 23390 and SKF 38393 (1 ~.M) and after 
washing out the antagonist. 
(D) Plot of peak ramp current as a function f 
time after seal rupture. Application of 6-chloro- 
APB decreased currents. Blocking N- and 
P-type currents eliminated the modulation by 
APB; washing restored APB's ability to modu- 
late currents. The inset is a summary of the 
effects of ~-CgTx (1-3 ~M) alone and in combi- 
nation with co-AgTx (100 nM) on the D, modula- 
tion. Recordings in (A), (B), and (D) were ob- 
tained with a 0.1 mM BAPTA internal solution; 
(C) used 5 mM EGTA. 
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Figure 3. Phosphodiesterase Inhibitors Poten- 
tiate the Effects of D~ Agonists, and cAMP Ana- 
logs Mimick Them 
(A) Plot of peak ramp current as a function 
of time after seal rupture. The application of 
6-chloro-APB (200 I~M) produced amodest re- 
duction in peak current. Coapplication ofthe 
phosphodiesterase inhibitor IBMX (1 mM) po- 
tentiated the effects of the D~ agonist. 
(B) Current races from the cell used to con- 
struct (A). Points at which the records were 
taken are denoted by asterisks. The inset is a 
box plot summary of the potentiation by IBMX 
(n = 4). 
(C) The cAMP analog, Sp-cAMPS (50 ~M), also 
reduced currents. Shown is a plot of peak ramp 
currents as a function of time after seal rupture. 
(D) Representative current races taken from 
the records used to construct (C). Times of the 
traces are denoted by asterisks in (C). The inset 
is a box plot summary of the percentage r duc- 
tion in peak current amplitude produced by 50 
~.M Sp-cAMPS in a sample of 10 neurons. All 
recordings were obtained with 0.1 mM BAPTA 
internals. 
evoked by voltage ramps was approximately 20% (Figure 
2B, inset). The response to D~ agonists (500 nM to 1 pM) 
was antagonized by SCH 23390 (1 IIM; n = 4), suggesting 
mediation by a Dl-class receptor (Figure 2C). Application 
of the 5-HT2 receptor antagonist ketanserin (10 I~M) did 
not affect the response to D~ agonists (data not shown). 
D~a receptors are coupled to cellular effectors through 
Gs or Go, proteins (Sibley and Monsma, 1992; Herve et 
al., 1993). To test for the involvement of a G protein in 
the modulation of Ca 2÷ currents, cells were dialyzed with 
GTPyS (400 ~M; data not shown; Breitweiser, 1991). After 
4 min of dialysis, the reduction in currents produced by 
SKF 38393 did not fully reverse (n = 6). The median rever- 
sal was 48%, significantly smaller than in neurons dialyzed 
with GTP (92%; p < .05, Kruskal-Wallis ANOVA). Longer 
dialysis times led to less recovery. 
N- and P-Type Currents Are Reduced by D1 Agonists 
In adult rat medium spiny neurons (>4 weeks postnatal), 
Ca 2+ currents are almost entirely of the HVA type (Bargas 
et al., 1994). To determine which type of HVA current is 
modulated by D1 agonists, the ability of specific channel 
antagonists to block the modulation was examined. The 
N-channel blocker o~-conotoxin GVIA (co-CgTx; 1-2 I~M) 
only partially blocked the D~-mediated reduction (Figure 
2D, inset). However, coapplication of o~-CgTx and the 
P-channel blocker (o-agatoxin IVA (co-AgTx; 100-200 nM) 
completely eliminated the D~ modulation in most cells (6/ 
8; see Figure 2D, inset). A time course derived from peak 
ramp currents in 1 of these neurons is shown in Figure 
2D. Application of the D~ agonist 6-chloro-APB reversibly 
reduced currents. Subsequent coapplication of co-CgTx 
and (o-AgTx eliminated the ability of 6-chloro-APB to re- 
duce currents. The application of Cd 2÷ blocked all active 
currents, showing that only Ca 2÷ channels contributed to 
the ramp currents. The failure of 6-chloro-APB to have an 
effect during toxin application was not a consequence of 
rundown, as reversal of the toxin block by washing and 
strong depolarization (Mintz et al., 1992) re-established its 
ability to reduce currents. In their sensitivity to D~ agonists, 
currents reversibly blocked by (o-CgTx were not noticeably 
different from those irreversibly blocked by co-CgTx (see 
Bargas et al., 1994). 
Frequently, agonist-induced reductions in Ca 2+ current 
are voltage dependent (Bean, 1989; Beech et al., 1992; 
Elmslie, 1992). To determine whether the D~ receptor- 
mediated reduction exhibits a similar dependence, the 
ability of a strong depolarizing prepulse to affect the modu- 
lation was examined. Prepulses (30 ms) to +100 mV only 
modestly reduced the modulation produced by D~ agonists 
(data not shown). The average modulation after the pre- 
pulse was 84% (_+ 6%; n = 8) of the control modulation, 
suggesting that most if not all of the D~ effects were medi- 
ated by a mechanism that lacks a strong voltage depen- 
dence. 
The Effects on N- and P-Type Currents Depend upon 
Activation of PKA and a Protein Phosphatase 
The best-characterized consequence of Dl-class receptor 
stimulation in the neostriatum is the activation of adenylyl 
cyclase and the formation of cAMP (Stoof and Kebabian, 
1984). If the effects of D1 agonists were mediated by this 
pathway, then prolonging the lifetime of cAMP by inhibiting 
metabolism by phosphodiesterase should potentiate the 
agonist-induced modulation. As shown in Figure 3A, the 
application of the membrane-permeant phosphodiester- 
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Figure 4. Activators of PKA Occlude the Ef- 
fects of D1 Agonists, and Inhibitors of PKA 
Block the D~ Modulation 
(A) Saturating concentrations of D, agonist and 
cAMP analog occlude one another. Shown is 
a plot of peak ramp currents. Application of 
the D1 agonist 6-chloro-APB (4 p.M) reversibly 
reduced peak currents. Application of cpt- 
cAMP (200 IIM) also decreased currents by a 
similar amount. The subsequent application of 
6-chloro-APB had no further effect on currents. 
Washing led to a recovery in current ampli- 
tudes. Reapplication of 6-chloro-APB showed 
the modulation was still intact. The inset shows 
a box plot of the modulation produced by the 
D1 agonist in the presence of cpt-cAMP (as a 
percentage of the modulation in the absence 
of cpt-cAMP) in a sample of 10 cells. 
(B) A peak current plot showing the H-9 (10 
p.M) inhibition of the modulation produced by 
6-chloro-PB (1 I~M). After the 6-chloro-PB appli- 
cation, co-CgTx (2 I~M) and o)-AgTx (100 nM) 
were coapplied, showing a substantial portion 
of the current was carried by N- and P-type 
channels. Washing of the toxins led to a partial 
recovery. Reapplication of agonist led to a 
modulation of the recovered current. Similar 
results were seen in 3 other neurons. The inset 
is a box plot showing the percentage of the 
control D~ modulation produced by a D~ agonist 
2-3 min after application of H-89 (2-5 p,M) or 
H-9 (10 pM; n = 12). 
(C) H-89 blocks the effects of D~ agonists. Plot 
of peak ramp currents as a function of time 
after seal rupture. Application of the D~ agonist 
6-chloro-PB (2 I~M) reversibly reduced peak 
currents. Application of the PKA inhibitor H-89 
(2 ~M) decreased peak currents and blocked 
the effects of the D~ agonist. 
(D) The effects of H-89 on whole-cell currents were occluded by Rp-pCPT-cGMPS (100 I~M). A peak current plot is shown. Application of H-89 (2 
pM) reversibly decreased peak currents. Subsequent application of Rp-pCPT-cGMPS also reduced currents; application of H-89 produced only 
a small additional decline to the current level seen when first applied. The inset shows a box plot of the reduction produced by H-89 in the presence 
of RpopCPT-cGMPS as a percentage of the reduction produced by H-89 alone. All recordings were obtained with 0.1 mM BAPTA internals. 
ase inhibitor isobutylmethylxanthine (IBMX; 1 raM) en- 
hanced the effects of subsaturating concentrations of the 
D1 agonist 6-chloro-APB (100-200 nM) from 50% to 420% 
(Figure 3B, inset). Representative current traces are 
shown in Figure 3B. The adenylyl cyclase stimulant for- 
skolin (1 ~M) also consistently reduced currents (n = 6), 
whereas the inactive 1,9-dideoxyforskolin (1 I~M) did not 
(data not shown). 
An alternative to stimulation of adenylyl cyclese is the 
application of membrane-permeant analogs of cAMP. 
Several cAMP analogs (8-bromo-cAMP, cpt-cAMP, and 
Sp-cAMPS) were tried with similar results; all reversibly 
reduced currents when applied alone. In 16/20 neurons 
(80%), relatively low concentrations of the cAMP analogs 
cpt-cAMP and Sp-cAMPS (25-100 I~M) reduced peak cur- 
rents. The median reduction in this group was similar to 
that seen with D1 agonists (cf. Figure 3D, inset; Figure 2B, 
inset), but higher concentrations (500-1000 I~M) reduced 
currents more strongly. An example of the reduction in 
currents produced by the cAMP analog Sp-cAMPS (50 
I~M) is shown in Figure 3C. Representative current traces 
are shown in Figure 3D. In this cell, as in several others 
(6/16), the cAMP analog produced a reduction in currents 
that appeared to desensitize with maintained application 
(see below). 
If Dt agonists were exerting their effect through the 
cAMP cascade, then saturating concentrations of cAMP 
analogs should occlude the modulation produced by D1 
agonists. This was the case. As shown in Figure 4A, 
6-chloro-APB (5 ~M) reversibly decreased currents, as did 
cpt-cAMP (200 I~M). However, in the presence of cpt- 
cAMP, 6-chloro-APB did not reduce peak currents further. 
The median modulation by 6-chloro-APB after application 
of cpt-cAMP was 12% of the control modulation (range 
0o-48o  ; n = 10; Figure 4A, inset). 
In eukaryotic cells, the principal cellular target of cAMP 
is thought to be the regulatory subunit of PKA. If D1 ago- 
nists exert their effects on N- and P-type channels by acti- 
vating PKA, then inhibiting PKA should block the effects 
of receptor activation. Experiments dialyzing neurons with 
the PKA inhibitor PKI [5-24] (10 IIM) were consistent with 
this hypothesis. The modulation by 6-chloro-APB was re- 
duced by84% (_.+ 18% [SEM]; n = 4) 15 min after begin- 
ning PKI dialysis; in control cells, the modulation was at- 
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Figure5. The Reduction in Currents Pro- 
duced by D~ Agonists or cAMP Analogs Is 
Blocked by Phosphatase Inhibitors 
(A) Plot of peak ramp current after seal rupture. 
Application of cpt-cAMP (100 #.M) decreased 
currents reversibly. Coapplication of the phos- 
phatase inhibitor okadaic acid (1 pM) attenu- 
ated the effects of cpt-cAMP and promoted an 
enhancement of current. The inset is a box plot 
summary of the cpt-cAMP-induced reduction 
in peak current after application of okadaic acid 
(n = 8). 
(B) Current races taken from the records used 
to construct (A). Traces were taken from the 
points denoted by asterisks in (A). 
(C) Dialysis with phospho-DARPP-32 peptide 
either blocked the effects of D1 agonists or al- 
tered the pattern of response, leading to an 
enhancement of currents. Shown is a plot of 
peak ramp currents after seal rupture with 
phospho-DARPP-32 (200 pM) in the patch pi- 
pette. Application of 6-chloro-PB (2 I~M) in- 
creased peak current; reversal was slow and 
partial with washing. Reapplication of 6-chloro- 
PB further increased currents. The inset is a 
summary of the number of phospho-DARPP- 
32-dialysed cells showing current enhance- 
ment or no modulation in response to 6-chloro- 
PB application (n = 8). 
(D) Current races taken from the records used 
to construct (C). Traces were taken from the 
points denoted by asterisks in (C). All re- 
cordings were obtained with 0.1 mM BAPTA 
internals. 
tenuated by 32% ('4- 12%; n = 4) over the same period 
(data not shown). Additional evidence came from experi- 
ments using the membrane-permeant PKA inhibitors H-89 
and H-9 (Hidaka and Kobayashi, 1992). As shown in Figure 
4B, after the application of H-9 (10 I~M), the Dt modulation 
was almost completely eliminated. H-9 alone, however, 
reduced whole-cell currents. Nevertheless, the impact of 
H-9 on the Dt modulation was not simply a consequence 
of the elimination of N- and P-type currents, as the N- and 
P-channel antagonists co-CgTx and co-AgTx further re- 
duced the peak current. After partially washing off the tox- 
ins and H-9, reapplication of 6-chloro-PB again modulated 
the whole-cell current. Shown in the inset are the results 
from a sample of 12 cells in which the effects of either 
6-chloro-PB or 6-chloro-APB were tested 3-4 rain after 
beginning superfusion with H-9 (10 IIM) or H-89 (1-2 ~M). 
The median modulation after PKA inhibition was reduced 
nearly 80%. As shown in Figure 4C, the pattern of effects 
of H-89 was similar to that of H-9. 
The ability of H-89 and H-9 to affect whole-cell currents 
in the absence of any intentional stimulation suggests that 
either PKA or another kinase sensitive to these inhibitors 
was active. This was not an artifact of the acute dissocia- 
tion procedure, as H-89 had a similar impact on cultured 
neostriatal neurons (n = 5). The effects of H-89 on whole- 
cell currents were just noticeable at 1 p.M and saturated 
near 10 ~M (data not shown); dose-response data were 
well fit with a single isotherm having an ICs0 of 4.7 I~M 
(data not shown). Within this concentration range, H-89 
is believed to inhibit cyclic GMP-dependent kinase (PKG) 
but not PKC or calmodulin-dependent kinase II (Hidaka 
and Kobayashi, 1992). To test for the involvement of PKG, 
the membrane-permeant, selective PKG inhibitor Rp-8- 
pCPT-cGMPS (100 ~M; Butt et al., 1992, 1994; Meriney 
et al., 1994) was applied. As shown in Figure 4D, the ef- 
fects of H-89 were almost completely occluded by prior 
application of Rp-8-pCPT-cGMPS. Superfusion with the 
membrane-impermeant PKG inhibitor Rp-cGMPS (100 
~M) had no effect on currents (n = 4). At the bottom of 
the panel is a box plot showing the effect of H-89 after 
application of the PKG inhibitor as a percentage of the 
effect of H-89 alone. These results suggest that in striatal 
neurons basal PKG activity is relatively high and may be 
involved in the maintenance of Ca 2+ currents. 
Previous studies examining the effects of PKA activation 
on neuronal Ca 2÷ currents have suggested that phosphory- 
lation enhances rather than reduces N- and P-type cur- 
rents (Gross et al., 1990; Mogul et al., 1993). On the face 
of it, this seems at odds with our results. It is possible that 
striatal N- and P-type Ca 2+ channels are different from 
those in other neurons, but this seems unlikely (Bargas 
et al., 1994). Another possibility is that the Dr-mediated 
modulation was brought about by phosphorylation of a 
regulatory protein. Protein phosphatases are obvious can- 
didates. As shown in Figure 5A, the phosphatase inhibitor 
okadaic acid (1 tIM) blocked the effects of the cAM P analog 
cpt-cAMP. The inset shows the statistical summary from 
8 neurons; the median current reduction with coapplica- 
tion of okadaic acid was 5% of the control value. In some 
neurons (see below), sustained application of Dt agonists 
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Figure6. Currents Were Occasionally En- 
hanced in the Absence of Phosphatase Inhib- 
tors 
(A) Percentage of neurons displaying an en- 
hancement in peak current amplitude after the 
application of a D1 agonist (6-chloro-APB or 
6-chloro-PB) or Sp-cAMPS (50-100 p_M). The 
percentages are broken down by recording 
condition. The left column (hi chelator) repre- 
sents recordings with 5-20 mM EG'I'A or 
BAPTA in the patch pipette and no added Ca 2+ 
(n = 88); the middle column (Io chelator), re- 
cordings with 0-0.1 mM BAPTA internals (n = 
37); the right column (+PP inhibitor), re- 
cordings with 0.1 mM BAPTA internals in the 
presence of okadaic acid (1 pM) or calyculin A 
(100 nM; n = 24). 
(B) A peak current time course from a cell in 
which sustained application of the D1 agonist 
(6-chloro-APB; 1 llM) led to an enhancement 
of peak currents. 
(C) Representative current traces from (B). 
Sample points in (B) are denoted by asterisks. 
(D) Sharp-electrode, current-clamp recording 
from a striatal neuron in the slice preparation. 
The slice was bathed in 5 mM TEA-containing 
salt solution to allow visualization of the Ca 2+ 
plateau potential. Application of 6-chloro-PB in- 
duced an enhancement of the plateau that re- 
versed with washing. Each trace is an average 
of three successive sweeps. Recordings used 
in (A)-(C) were obtained with 0.1 mM BAPTA 
internals. 
or cAMP analogs in the presence of okadaic acid produced 
a slow enhancement in current (Figures 5A and 5B). 
At 1 I~M, okadaic acid will effectively inhibit both PP2A 
and PPI .  To determine whether the effects of okadaic acid 
are solely a consequence of PP1 inhibition, neurons were 
dialyzed with the PP1 peptide inhibitor, phospho-DARPP- 
32 [8-38] (Hemmings et al., 1990). Dialysis with the phos- 
pho-DARPP-32 peptide (100 IxM) had effects similar to 
those of extrinsically applied okadaic acid, eliminating re- 
sponses in most neurons (5/8) and promoting D~ agonist-  
induced enhancement of currents in a smaller subset (3/8). 
An example from 1 of these neurons is shown in Figures 
5C and 5D. Reversal of the enhancement was very slow 
in cells dialyzed with phospho-DARPP-32, as expected if 
reversal were dependent upon phosphatase activity. In 
14 control cells recorded under the same conditions (but 
without phospho-DARPP-32), D1 agonists reduced peak 
currents in 64% of the cells (9/14) and increased currents 
in none. 
The D1-PKA Pathway Augments L-Type Currents 
in a Subset of Neurons 
In the experiments with the phosphatase inhibitors, D1 ag- 
onists increased peak currents in 46% of the cells studied 
(11/24). In the absence of phosphatase inhibitors, D~ ago- 
nists rarely had this effect. As shown in Figure 6A, an 
augmentation of currents was seen in just under 10% of 
all cells recorded with intracellular Ca 2+ buffered to low 
levels with EGTA (5 mM) or BAPTA (5 mM; n = 88). The 
frequency was similar in a sample with nominal (0-0.1 
mM) BAPTA buffering (n = 22). Our failure to see a slow 
enhancement in currents more frequently may have been 
a consequence of its being masked in brief agonist appli- 
cations by the rapid reduction of N- and P-type currents. 
If true, the modulation should appear to "desensitize" with 
sustained application of agonist (see Figure 3C). In a sam- 
ple of 10 neurons in which agonist was applied for 1 min 
or more, 3 neurons exhibited a biphasic response. A plot 
of peak current as a function of time for 1 of these neurons 
is shown in Figure 6B; representative current traces are 
shown in Figure 6C. Initially, 6-chloro-APB (1 ixM) de- 
creased peak currents. However, within 10-15 s, the peak 
current began to increase. Typically, as the current grew, 
the peak current shifted toward more negative membrane 
potentials, and deactivation rates slowed (Figure 6C). With 
the initiation of washing, currents continued to increase 
and only slowly returned to control amplitudes and voltage 
dependence. A similar pattern of response was seen in 
3/7 neurons exposed to cAMP analogs (cpt-cAMP or Sp- 
cAMPS) for a prolonged period (>1 rain; data not shown). 
This suggested that, although the mechanism was in place 
in about half of all medium-sized cells, the enhancement 
was not manifested in our usual stimulation paradigm. 
To determine whether a similar phenomenon could be 
seen in cells not subjected to whole-cell dialysis, sharp- 
electrode recordings from medium spiny neurons were 
made in brain slices treated with tetraethylammonium 
(TEA; Pineda et al., 1992). Previous work has shown that 
the somatic Ca 2+ plateau potentials elicited in this condi- 
tion are dominated by L-type currents (Cherubini and Lan- 
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Figure 7. The D~-Induced Enhancement of 
Currents Is Blocked by Nifedipine and PKA In- 
hibitors 
(A) Plot of peak current as function of time fol- 
lowing seal rupture. Application of Sp-cAMPS 
(100 ~M) in the presence of okadaic acid (500 
nM) increased currents in a partially reversible 
manner. Nifedipine (5 ~.M) reduced peak cur- 
rents and blocked the ability of Sp-cAMPS to 
enhance currents. Washing the nifedipine re- 
stored currents to control evels and the ability 
of Sp-cAMPS to modulate peak current. 
(B) Representative current races taken before 
and during the first Sp-cAMPS application and 
then during exposure to nifedipine. Traces 
were taken from the points denoted by aster- 
isks in (A). 
(C) Plot of peak ramp currents as a function of 
time after seal rupture. Application of 6-chloro- 
PB (2 #.M) increased currents in the presence 
of calyculin A (50 nM). Washing on H-89 (5 I~M) 
decreased currents to below control levels. 
Reapplication of 6-chloro-PB transiently in- 
creased currents; subsequent application of 6- 
chloro-PB had little or no effect. The inset 
shows a box plot summary of the percentage 
enhancement of the current produced by the 
second 6-chloro-PB application in the pres- 
ence of H-89. 
(D) Representative current races from the first 
application of 6-chloro-PB in the presence of 
H-89. Sample points in (C) are denoted by as- 
terisks. All recordings were obtained with 0.1 
mM BAPTA internals. 
fumey, 1987). In half of the neurons studied (3•6), sus- 
tained application of the D1 agonist 6-chloro-PB to the slice 
prolonged the duration of the Ca2+-dependent plateau (Fig- 
ure 6D). With washing, the plateau returned to control 
lengths. 
In agreement with the inference that L-type currents 
were targeted, the L-channel antagonist nifedipine (5 I~M) 
significantly reduced the effects of cAMP analogs in the 
presence of phosphatase inhibitors (n = 5). A plot of peak 
ramp currents as a function of time in one of these experi- 
ments is shown in Figure 7A. In the presence of okadaic 
acid (500 nM), Sp-cAMPS (50 I~M) enhanced currents in 
a partially reversible manner. The application of nifedipine 
decreased peak currents and blocked the effects of Sp- 
cAMPS. Washing off the nifedipine restored currents to 
their preapplication levels. Reapplication of Sp-cAMPS 
showed that the cell was still capable of responding. To 
confirm that only Ca 2+ currents were being modulated, 
Cd 2+ was applied and Sp-cAMPS reapplied. Representa- 
tive current traces before and during the application of 
nifedipine are shown in Figure 7B. In our sample of 5 neu- 
rons, the median modulation in the presence of nifedipine 
was 6% of the control modulation (range 0%-22%;  Figure 
7A, inset). The application of N- and P-type current block- 
ers ((o-CgTx and co-AgTx) had no effect on the ability of 
D~ agonists or cAMP analogs to enhance currents (n = 
5). These results suggest that the slow enhancement of 
currents in response to D#cAMP analogs was due to mod- 
ulation of an L-type current. 
To test whether PKA activation was responsible for the 
effects of D1 agonists and cAMP analogs, neurons were 
treated with the PKA inhibitor H-89. A plot of peak current 
amplitude as a function of time in one experiment is shown 
in Figure 7C. In the presence of the PP1 and PP2A inhibitor 
calyculin A (50 riM), application of the D1 agonist 
(6-chloro-PB) enhanced peak currents. Subsequent appli- 
cation of H-89 decreased currents to below control levels. 
Application of 6-chloro-PB in the presence of H-89 initially 
increased currents, but with maintained exposure the en- 
hancement was lost. Reapplication of 6-chloro-PB evoked 
only a small modulation. Representative current traces 
taken in the presence of H-89 before and during the 
6-chloro-PB application are shown in Figure 7D. This pat- 
te rn - loss  of the modulation only after activation of the 
pathway in the presence of H-89--was seen in every neu- 
ron examined (n = 8). The inset in Figure 7C is a box plot 
summarizing the percentage modulation (relative to the 
first modulation in H-89) produced by a second 6-chloro- 
PB application more than 50 s after the end of the first 
application. In control solutions, there was very little atten- 
uation or desensitization of responses with agonist appli- 
cations repeated at this frequency; on average, the third 
modulation in a sequence like that of Figure 7C was 78% 
of the initial response (n = 4). Waiting longer between 
applications (2-3 min) in the presence of H-89 did not 
enhance the ability of the agonist to produce a modulation 
(n = 3). Washing H-89 from the neuron restored the ability 
of 6-chloro-PB to modulate currents in neurons held long 
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enough to perform the test (n = 3). The ability of H-89 to 
block the effects of D1 agonists and exogenously applied 
cAMP suggests that their actions on L-type currents were 
mediated by PKA. 
Discussion 
D1 Receptors Modulated N- and P-Type Currents 
In the majority of medium-sized neostriatal neurons, the 
application of D~ receptor agonists reversibly reduced 
N- and P-type Ca 2÷ currents. The modulation was antago- 
nized by the Dl-class receptor antagonist SCH 23390, ar- 
guing that the effects were mediated by either D~a or D~b 
receptors. Based on the relative abundance of mRNA for 
these two receptor subtypes (Sibley and Monsma, 1992), 
it is reasonable to assume that the D~a receptor is most 
likely to have been responsible for our effects. This recep- 
tor, like other dopamine receptors, couples to intracellular 
effectors through G proteins. As expected of a G protein- 
dependent process (Breitweiser, 1991), the agonist-induced 
modulation did not reverse (or did so partially) when the 
dialysate contained the nonhydrolyzable analog of GTP 
(GTPyS). 
In a variety of other neurons, receptor-activated G-protein 
subunits directly interact with HVA Ca 2÷ channels, shift- 
ing their voltage dependence in such a way as to reduce 
whole-cell currents except at very depolarized potentials 
(Bean, 1989; Beech et al., 1992; Elmslie, 1992). There are 
several reasons to believe that striatal D1 receptors do not 
rely upon this mechanism. First, inhibitory coupling of this 
sort has been described primarily for pertussis toxin-sen- 
sitive G proteins (Rosenthal et al., 1990; Hille, 1992), 
whereas D~ receptors couple to G proteins that are insensi- 
tive to this toxin. Second, effects on Ca 2+ currents medi- 
ated by direct, G-protein signaling are typically fast (com- 
plete in 1-2 s; Brown, 1991), in contrast to the relatively 
slow kinetics of the D~ modulation. Third, direct G-protein 
interactions are typically strongly voltage-dependent (e.g., 
Beech et al., 1992; Elmslie, 1992), whereas the D1 modula- 
tion was only weakly affected by depolarizing prepulses. 
Lastly, as discussed below, the modulation produced by 
D1 agonists was mimicked by soluble second messengers 
and blocked by kinase and phosphatase inhibitors. To- 
gether, these observations point to an alternative mecha- 
nism involving cytosolic signaling elements. 
The oldest and best-characterized cytosolic link of D~ 
receptors is to adenylyl cyclase and the production of 
cAMP (Stoof and Kebabian, 1984). Membrane-permeant 
analogs of cAM P mimicked D1 receptor stimulation, as did 
the adenylyl cyclase stimulant forskolin. Moreover, inhibi- 
tion of the cAM P-degradative nzyme phosphodiesterase 
potentiated the D~-induced modulation. The ability of 
cAMP analogs to occlude the D~ modulation also argues 
for a shared pathway. 
The Effects on N- and P-Type Currents Were 
Mediated by a PKA-PP1 Cascade 
Further evidence that D1 receptors acted through elevation 
of cytosolic cAMP levels was the ability of PKA inhibitors 
to block the effects of D1 agonists and cAMP analogs. In 
neostriatal neurons, most of the known effects of eleva- 
tions in cytosolic cAMP are mediated by PKA (Walaas and 
Greengard, 1991). The isoquinoline PKA inhibitors H-89 
and H-9 (Hidaka and Kobayashi, 1992), as well as PKI [5- 
24] (Cheng et al., 1986), were able to reduce substantially 
the effects of D1 agonists or cAMP analogs. The incom- 
plete block of D1 effects in some neurons may indicate 
the existence of another pathway or the failure of H-89 (or 
H-9) to permeate the cellular membrane adequately and 
reach PKA. Previous studies with intact cells have used 
higher H-89 concentrations to overcome this limitation 
(Chijiwa et al., 1990; Geilen et al., 1992). However, the 
impact of the isoquinolines on whole-cell currents in the 
absence of PKA activators made the use of higher concen- 
trations problematic. The effect on basal whole-cell cur- 
rents appeared to result from the inhibition of PKG, as 
judged by the ability of the selective PKG inhibitor Rp-8- 
pCPT-cGMPS to occlude the effect (Butt et al., 1992, 1994; 
Meriney et al., 1994). Both H-89 and H-9 are known to 
inhibit PKG in this concentration range, but not PKC or 
Ca2+/calmodulin-dependent kinase II (Hidaka and Koba- 
yashi, 1992). In spite of this complication, the use of mem- 
brane-permeant inhibitors like H-89 has several advan- 
tages over agents introduced by dialysis (e.g., PKI and 
Rp-cAMPS), including the ability to obtain control records 
prior to the application of the inhibitor in order to verify 
the integrity of the signaling pathway, to differentiate non- 
specific rundown from inhibitor effects by controlling the 
timing of inhibitor application, and to reverse inhibitor ef- 
fects by washing, again excluding nonspecific rundown as 
a causal element. The fact that both membrane-permeant 
and -impermeant inhibitors were able to attenuate the ef- 
fects of D1 agonists and cAMP analogs makes a more 
convincing case for the involvement of PKA than data from 
either agent alone. 
Consensus PKA phosphorylation sites are predicted 
from the sequences of the pore-forming ~1 subunit of puta- 
tive N-, L-, P- and Q-type HVA Ca 2÷ channels (Mori et al., 
1991; Snutch et al., 1991; Dubel et al., 1992). Previous 
studies of PKA effects on N- (Gross et al., 1990) and P-type 
currents (Mogul et al., 1993) have suggested that phos- 
phorylation enhances rather than reduces these currents. 
Our results are not at odds with this conclusion. In our 
cells, the effects of PKA on N- and P-type currents were 
blocked by the mixed PPI/PP2A inhibitor okadaic acid 
and the PPl-selective inhibitor phospho-DARPP-32 [8- 
38] arguing that activation of PKA led to dephosphorylation 
of these channels. This seemingly paradoxical result has 
a precedent. In skeletal muscle, the catalytic subunit of 
PP1 (PPlo) is largely bound to targeting proteins, such as 
the glycogen-targeting protein (PP1G). PKA phosphoryla- 
tion of PP1G releases PPlc into the cytosol, freeing it to 
dephosphorylate substrates other than those associated 
with glycogen metabolism (Hubbard and Cohen, 1993). 
Similar targeting proteins are present in the brain (Sim et 
al., 1994). Because PPlc is found in regions of synaptic 
contact in neostriatal neurons (Ouimet, da Cruz e Silva and 
Greengard, unpublished data), PPla-like proteins should 
also be present in these locations. PPlo released from 
these PPIQ-like proteins by PKA phosphorylation may de- 
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phosphorylate nonsynaptic dendritic proteins, of which 
N- and P-type channels are examples. Coincident phos- 
phorylation of DARPP-32 and inhibitor-1 could then ter- 
minate the cascade by inhibiting the freed PPlc. This 
sequence of events would allow the rapid rephosphory- 
lation of the channel proteins and reversal of the modula- 
tion. Preliminary experiments with neurons in which the 
DARPP-32 gene has been knocked out are consistent with 
this model (Surmeier, Feinberg, and Greengard, unpub- 
lished data). 
This model assumes that N- and P-type channels are 
largely phosphorylated at PKA sites prior to initiation of 
the cascade. The apparent high basal activity of PKG, 
which has similar substrate specificity to PKA (Glass, 
1990), may be responsible for this phosphorylation tone. If 
this tone were reduced, then activation of the PKA cascade 
could result in a net increase in channel phosphorylation 
and currents. Preliminary experiments in which neurons 
were dialyzed with Rp-cGMPS and then exposed to Dt 
agonists are consistent with this interpretation (Surmeier 
et al., unpublished data). 
PKA-Mediated Modulation of L-Type Currents 
The suggestion that D~ receptor-mediated activation of 
PKA leads to phosphorylation of L-type channels is consis- 
tent with studies of its regulation in other tissues. In skele- 
tal muscle and heart, phosphorylation of L-type channels 
enhances current (Trautwein and Hescheler, 1990; Hart- 
zell et al., 1991). The enhancement is due to a modal shift 
in gating that is manifested as an increase in peak current, 
a negative shift in the voltage dependence of gating, and 
a slowing of deactivation rates (Yue et al., 1990). In neostri- 
atal neurons recorded in the presence of phosphatase 
inhibitors, nifedipine-sensitive, L-type currents were en- 
hanced in precisely this way by D~ agonists or cAMP ana- 
logs. Similar results in response to 13-adrenergic agonists 
(which activate PKA) have been reported in hippocampal 
neurons (Gray and Johnston, 1987). The loss of this modu- 
lation in the presence of H-89 argues that the response 
was PKA mediated. 
Molecular cloning studies have shown that the cardiac 
form of the L-type Ca 2+ channel ~1 subunit is expressed 
in the striatum (Snutch et al., 1990). Single-cell expression 
profiling has also shown that mRNA for this subunit is 
abundant in most medium-sized neostriatal neurons (Sur- 
meier et al., unpublished data). As PKA phosphorylation 
of this subunit is thought o produce the alteration in gating 
(Kldckner et al., 1992), it is not surprising that neostriatal 
neurons manifest a modulatory pathway similar to that 
found in muscle. Modulation of L-type currents was not 
seen in every neuron, however. Although our sample sizes 
were small (n = 24), the percentage of neurons displaying 
enhancement in the presence of phosphatase inhibitors 
was smaller (48%) than the percentage of neurons dis- 
playing the modulation of N- and P-type currents (67%), 
suggesting that something other than the presence of the 
D~ receptor dictated whether L-type channels were capa- 
ble of being modulated. The fact that only half of the neu- 
rons recorded with sharp electrodes in slices responded 
to D~-class agonists with an enhancement of the L-current- 
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Figure 8. Working Modelofthe D1 Signaling Cascade Targeting HVA 
Ca 2+ Channels in Rat Neostriatal Neurons 
dominated plateau potential is also consistent with this 
inference. 
Why then did stimulation of D1 receptors lead to an en- 
hancement of L-type currents in only a subset of neurons? 
There are several possible explanations. One is that L-type 
currents are simply not present in some neurons. This 
seems unlikely, however, as we have never failed to see 
a clear response to L-channel agonists or antagonists in 
neostriatal neurons (n > 150). Another possibility is that 
the basal phosphorylation of PKA/PKG sites on L-type 
channels is high enough in some cell types to preclude 
any further modulation. The apparently high basal level 
of PKG activity is consistent with this possibility. But if this 
were so, why then were L-type currents not affected in 
the same way as N- and P-type currents by D1 agonists? 
Furthermore, unresponsive neurons did not have currents 
that were indicative of pronounced, phosphorylation- 
dependent, L-type current enhancement (e.g., negatively 
shifted current-voltage relation and slowed deactivation 
kinetics). 
Another possible explanation is that striatal L-type chan- 
nels vary in their susceptibility to PKA-mediated enhance- 
ment. The capacity of PKA to modulate reconstituted, car- 
diac L-type channels is dependent upon the !3 subunit used 
to form the channel (KISckner et al., 1992). By varying the 
expression of different 15 subunits, neurons could effec- 
tively alter their sensitivity to this form of dopaminergic 
modulation. If"susceptible" channels were largely dephos- 
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phorylated at rest, then activation of PPlo should have no 
effect on them. Inhibition of PPlo (by either exogenous 
inhibitors like okadaic acid or native ones like phospho- 
DARPP-32) should lengthen the lifetime of the PKA phos- 
phorylated state of the channel, leading to an enhance- 
ment of channel gating and an increased Ca 2÷ flux. 
A Working Model 
Our working model of this signaling pathway is shown in 
Figure 8. The model incorporates well-established obser- 
vations and the results reported here. In the model, D~ 
receptors couple through a Gs-class protein to stimulate 
adenylyl cyclase. Stimulation of adenylyl cyclase elevates 
cytosolic cAMP levels, which activate PKA by promoting 
dissociation of regulatory and catalytic subunits. Activa- 
tion of PKA has several consequences. First, phosporyla- 
tion of the PPlc targeting protein releases PPlo into the 
cytosol, allowing it to dephosphorylate N- and P-type chan- 
nels. The dephosphorylation of these channels reduces 
whole-cell current carried by them ("active" to "inactive" 
transition). Second, phosphorylation of cytosolic DARPP- 
32 terminates this limb of the cascade by inhibiting the 
released PPlc. The site regulated by PPlo is probably 
phosphorylated by both PKA and PKG. Because of the 
apparent high basal activity of PKG, these PPlc sites on 
N- and P-type channels are hypothesized to be fully phos- 
phorylated at rest (bold type indicates the predominant 
state at rest). As a consequence, D~ receptor stimulation 
and activation of PKA lead to a transient, net dephosphory- 
lation of N- and P-type channels. 
Regulation of L-type channels uses similar mechanisms 
in our schema, but this pathway appears to be functional 
in only a subset of neurons. In these neurons, L-type chan- 
nels are hypothesized to be at least partially dephosphory- 
lated at rest. Phosphorylation of these channels by PKA 
enhances mode 2 gating and current flux through them. 
Functional Implications 
The mechanism utilized by the D1 pathway in modulating 
HVA Ca 2+ currents may help to explain D1 effects on synap- 
tic integration and to indicate the type of strategy employed 
in controlling long-term changes in synaptic strength. 
Studies looking at the effects of D~ agonists on the integ- 
rative behavior of neostriatal neurons have consistently 
found evidence for reduced responsiveness to excitatory 
inputs (Uchimura et al., 1986; Akaike et al., 1987; Cala- 
bresi et al., 1987; Ohno et al., 1987; Waiters et al., 1987; 
Hu et al., 1990). In particular, D1 agonists reduce the size 
of EPSPs evoked by stimulation of cortical afferent fibers. 
Studies of dendritic conduction of EPSPs have suggested 
that active conductances, particularly HVA Ca 2+ currents, 
are of importance in determining EPSP size as seen in 
the soma (Kim and Connors, 1993; Reuveni et al., 1993). 
Localization studies of HVA channels have shown that 
N- and P-type channels are prominent in dendrites, 
whereas L-type channels are largely somatic (Westen- 
broek et al., 1990, 1992; Usowicz et al., 1992; Hell et al., 
1993a). Our finding that D1 agonists decrease N- and 
P-type currents provides one mechanism by which the 
reduction in EPSP amplitude could be brought about. 
The fact that PPlc is an element in this signaling chain 
suggests that PKA regulation of targeting proteins, like 
PP1G, may be an important element in longer-term synap- 
tic changes. Why? Sustained changes in synaptic efficacy 
rely, at least in part, upon alterations in the phosphoryla- 
tion state of synaptic proteins, like glutamate receptors 
and Ca 2+ channels (Madison et al., 1991 ; Bliss and Coiling- 
ridge, 1993; M ulkey et al., 1994). As mentioned previously, 
PPlc and, by inference, PP1G are concentrated in these 
synaptic regions of medium spiny neurons. In hippocam- 
pal neurons (and presumably in neostriatal neurons as 
well), one form of synaptic plasticity, LTD, depends upon 
PPlo for its expression (Mulkey et al., 1994). LTD expres- 
sion in neostriatal neurons also requires activation of D1 
receptors (Calabresi et al., 1992), suggesting that PKA- 
mediated release of PPlc may be a critical element in the 
chain of events leading to changes in synaptic strength. 
In summary, we have shown that Dl-class agonists dif- 
ferentially modulate N-, P-, and L-type Ca 2÷ currents in 
adult neostriatal neurons th rough activation of the cAM P-  
PKA signaling cascade. In contrast to the effects on L-type 
currents, reductions in N- and P-type currents appeared 
not to be mediated directly by PKA but by an enhancement 
of PPlc activity directed to N- and P-type Ca 2÷ channels. 
These results provide a cellular and molecular framework 
within which the actions of D1 agonists on cellular excitabil- 
ity and synaptic regulation can be interpreted. 
Experimental Procedures 
Acute Dissociation Procedure 
Neostriatal neurons from adult (>4 weeks) rats were acutely dissoci- 
ated using procedures imilar to those we have described previously 
(Surmeier et al., 1992; Bargas et al., 1994). Briefly, rats were anesthe- 
tized with methoxyflurane and decapitated; brains were quickly re- 
moved, iced, and then blocked for slicing. The blocked tissue was cut 
in 400 p.m slices with a Vibroslice (Campden Instruments, London, 
England) while bathed in a low Ca 2+ (100 I~M), HEPES-buffered salt 
solution (140 mM sodium isethionate, 2 mM KCI, 4 mM MgCI2, 0.1 
mM CaCI2, 23 mM glucose, 15 mM HEPES [pH 7.4], 300-305 mosm/ 
liter). Slices were then incubated for 1-6 hr at room temperature 
(20°C-22°C) in a NaHCO3-buffered saline bubbled with 95% 02, 5% 
CO2 (126 mM NaCI, 2.5 mM KCI, 2 mM CaCI2, 2 mM MgCI2, 26 mM 
NaHCO3, 1.25 mM NaH2PO4, 1 mM pyruvic acid, 10 mM glucose [pH 
7.4 with NaOH], 300-305 mosm/liter); in later experiments ascorbic 
acid (200 p.M) and NG-nitro-L-arginine (100 I~M) were added to the 
holding solutions. All reagents were obtained from Sigma Chemical 
Co. (St. Louis, MO). Slices were then removed into the low Ca ~+ buffer, 
and with the aid of a dissecting microscope, regions of the dorsal 
neostriatum were dissected and placed in an oxygenated Cell-Stir 
chamber (Wheaton, Inc.) containing pronase (1-3 mg/ml) in HEPES- 
buffered Hank's balanced salt solution (Sigma Chemical Co.) at 35°C. 
Dissections were limited to tissue rostral to the anterior commissure 
to reduce the possibility of contamination from pallidum. Although pro- 
nasa treatment provided the highest yield of viable cells (all of the 
data shown in the figures were taken from pronase-treated neurons), 
other enzymes, such as papain and trypsin were tried with comparable 
results. After 20-30 min of enzyme digestion, tissue was rinsed three 
times in the low Ca 2., HEPES-buffered saline and mechanically disso- 
ciated with a graded series of fire-polished Pasteur pipettes. The cell 
suspension (2 ml) was then plated into a 35 mm Lux petri dish mounted 
on the stage of an inverted microscope containing 1 ml of HEPES- 
buffered Hank's balanced salt solution. After allowing the cells to settle, 
the solution bathing the cells was changed to our normal recording 
external solution. In some experiments, cultured cells were studied 
to determine whether the acute dissociation protocol had altered re- 
sponsiveness. In these experiments, cells were cultured and main- 
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tained in vitro as previously described (Surmeier et al., 1988; Bargas 
et al., 1991). 
Whole-Cell Recordings 
Whole-cell recordings employed standard techniques (Hamill et al., 
1981 ; Bargas et al., 1994). Electrodes were pulled from Coming 7052 
glass and fire polished prior to use. In some experiments, electrodes 
were coated with Sylgard. The internal solution consisted of 180 mM 
N-methyl-D-glucamine (NMG), 40 mM HEPES, 4 mM MgCI2, 5 mM 
EGTA or 0.1 mM BAPrA, 12 mM phosphocreatine, 2 mM Na2ATP, 
0.2 mM Na3GTP, and 0.1 mM leupeptin (pH 7.2-7.3 with H3PO4 or 
H2SO4; 265-270 mosm/liter; H2SO4 yielded considerably better re- 
cordings). In some experiments, NMG was replaced with Tris without 
altering current properties in any noticeable way (cf. Malecot et al., 
1988). All of the data presented were gathered using NMG as the 
internal cation. The pH of NMG solutions was measured with a Corning 
Model 476570 probe. The external solution consisted of 135 mM NaCI, 
20 mM CsCI, 1 mM MgCI~, 10 mM HEPES, 0.001 mM tetrodotoxin, 
2-10 mM CaCI2 or BaCI2, and 10 mM glucose (pH 7.3 with NaOH; 
300-305 mosm/liter; in some experiments, TEACI was used instead 
of NaCI as the major external salt). 
The D1 agonists dopamine and (_)  SKF 38393 were made up as 
concentrated stocks in dilute acid (pH < 4); stocks were diluted in 
normal external solution supplemented with ascorbic acid (0.1% w/ 
v) and protected from light. D1 agonists ( + ) SKF 82958 (6-chloro-APB) 
and ( + ) SKF 81297 (6-chloro-PB) (RBI, Natick, MA) were made up as 
concentrated stocks in ascorbic acid (0.1% w/v), diluted, and protected 
from light. The D1 antagonist (+) SCH 23390 was handled like SKF 
38393. 
Nifedipine and ( _+ ) BayK 8644 (RBI) were made up as concentrated 
stocks in 95% ethanol and diluted immediately before use. These 
solutions were protected from ambient light. Final ethanol concentra- 
tions never exceeded 0.05% (v/v; previous experiments had shown 
that this concentration had no effect on currents). ~-CgTx (Peninsula 
Lab., Belmont, CA; Calbiochem, San Diego, CA) was made up as a 
concentrated stock in water, aliquoted, and frozen; aliquots were 
thawed and diluted on the day of use. ~o-AgTx (Peptides International, 
Louisville, KY) was made up as a concentrated stock, aliquoted, and 
frozen; final dilutions were made in external media containing 0.01% 
cytochrome C. This concentration of cytochome C was used because 
0.1% (Mintz et al., 1992) had effects of its own on our currents, and 
dose-response experiments with o)-AgTx suggested that 0.01% (0.1 
mg/ml) was a sufficient carrier concentration with our perfusion tubing 
(largely Teflon). More recent work using this toxin (Sather et al., 1993) 
has also reported using this lower cytochrome C concentration without 
loss of activity. 
Forskolin and 1,9-dideoxyforskolin (Calbiochem) were made up as 
concentrated stocks in dimethylsulfoxide prior to dilution. Okadaic acid 
(Na ÷ salt), calyculin A, H-89, and H-9 (LC Laboratories, Woburn, MA) 
were made up as concentrated stocks in dimethylsulfoxide and frozen; 
aliquots were diluted immediately prior to use. IBMX (Sigma Chemical 
Co.) was added directly to external solutions, cAMP analogs 8-bromo- 
cAMP (Sigma Chemical Co.), adenosine-3'-5'cyclic monophosphoro- 
thioate (Sp-cAMPS), 8-(4-chlorophenylthio)-adenosine-3',5'-cyclic mo- 
nophosphate (8-cpt-cAMP; Biolog, La Jolla, CA) were made up as 
concentrated stocks in water and frozen; aliquots were diluted immedi- 
ately prior to use. The PKA inhibitor peptide (PKI [5-24]; Cheng et al., 
1986) and phospho-DARPP-32 peptide [8-38] (Hemmings et al., 1990) 
were synthesized as previously described. Both peptides were dis- 
solved in water and diluted in recording media immediately prior to 
use. 
E!ectrode resistances were typically 3-6 ME~ in the bath. Recordings 
were obtained with an Axen Instruments 200 patch-clamp amplifier 
and controlled and monitored with a PC 486 clone running pCLAMP 
(v. 5.0-5.5) with a 125 kHz interface (Axon Instr., Ino., Foster City, 
CA). After seal rupture, series resistance (7-15 M~) was compensated 
(70%-80%) and periodically monitored. Because whole-cell currents 
never exceeded 2 nA (usually <600 pA), errors in voltage owing to 
inadequate compensation should never have exceeded a few milli- 
volts. Recordings were made only from medium-sized neurons 
(6-12 I~m somal diameter) that had only a few short (<50 p.m) proximal 
dendrites. The adequacy of voltage control was assessed after com- 
pensation by examining the tail currents generated by strong depolar- 
izations. Cells in which tail currents did not decay rapidly and smoothly 
at subthreshold potentials were discarded. Drugs were applied with 
a gravity-fed "sewer pipe" system. The array of application capillaries 
(inside diameter, - 150 I~m) was positioned a few hundred microns 
from the cell under study. Solution changes were effected by altering 
the position of the array with a DC drive system controlled by a micro- 
processor-based controller (Newport-Klinger, Inc., Irvine, CA). Solu- 
tion changes were complete within less than a second; the time con- 
stant of Cd 2÷ block of Ca 2÷ current was 400 ms. Potentials were not 
corrected for the liquid junction potential with the NMG-PO4 internal 
solution, which was estimated to be 7 mV. 
Statistical analyses (including nonlinear curve fitting) were per- 
formed with SYSTAT (ver. 5, SYSTAT, Inc., Evanston, IL). Sample 
statistics are given either as means with standard deviations or as 
medians. Box plots were used for graphic presentation of the data 
because of the small sample sizes (Tukey, 1977). The box plot repre- 
sents the distribution as a box with the median as a central line and 
the hinges as the edges of the box (the hinges divide the upper and 
lower halves of the distributions in half). The inner fences (shown as 
a line originating from the edges of the box) run to the limits of the 
distribution excluding outliers (defined as points that are more than 
1.5 times the interquartile range beyond the inner fence; Tukey, 1977); 
outliers are shown as asterisks or circles. 
Slice Recordings 
Brain slices were obtained from albino Wistar rats using procedures 
described elsewhere (Bargas et al., 1989). Briefly, a 400 ~m thick 
neostriatal slice was held submerged in a recording chamber at 30°C - 
34°C. The extracellular saline consisted of 120 mM NaCt, 3 mM KCI, 
25 mM NaHCO3, 2 mM CaCI2, 1 mM MgCI2, and 11 mM glucose (300 
mosm/liter [with glucose]; pH 7.4; the solution was saturated with 95% 
02 and 5O/o CO2). TEA (Sigma) and dopamine D1 agonist 6-chloro-PB 
(5 ~M) were added from stock solutions to the bath saline. Complete 
solution exchanges within the recording chamber took about 2 min. 
Recordings used conventional intracellular techniques: a high input 
impedance electrometer with an active bridge circuit. Microelectrodes 
were filled with K-acetate (3-4 M), having DC resistances of 80-120 
M~3. Plateau potentials were evoked in the presence of TEA (10 mM) 
by intracellular injection of rectangular current steps (>150 ms) from 
the resting membrane potential (around -80 mV) at a frequency of 
0.25-0.5 Hz. 
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